Candriam Equities L Biotechnology Class I GBP CapRegister to Unlock Ratings |
Growth Of 1000 (GBP) | 31/03/2024 |
|
Annual Returns (GBP) | 31/03/2024 | |||||||
2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 31/03 | |
Price Return | 16.06 | -4.56 | 28.66 | 17.29 | -1.63 | 9.66 | 1.50 | 3.71 |
+/- Category | 5.77 | 3.41 | 8.46 | -8.68 | 7.40 | 17.50 | 2.79 | 1.41 |
+/- Category Index | 0.87 | -2.71 | 11.95 | -15.65 | -1.93 | 7.20 | -5.83 | -4.78 |
% Rank in Category | 22 | 32 | 14 | 61 | 35 | 3 | 30 | 44 |
Trailing Returns (GBP) | 30/04/2024 | ||
Total Returns | +/- Category | +/- Category Index | |
1 Day | -0.59 | -1.29 | -1.48 |
1 Week | -0.85 | -1.28 | -1.77 |
1 Month | -5.29 | -0.10 | -4.00 |
3 Months | -3.17 | -0.87 | -7.89 |
6 Months | 12.48 | 11.31 | -2.56 |
YTD | -1.78 | 6.24 | -9.16 |
1 Year | 4.40 | 14.56 | -8.59 |
3 Years Annualised | 3.65 | 7.46 | -3.37 |
5 Years Annualised | 8.43 | 5.09 | -3.81 |
10 Years Annualised* | 15.44 | 5.62 | 3.80 |
Category: Sector Equity Biotechnology | |||
Category Index: Morningstar Gbl Biotechnology NR USD |
Quarterly Returns (GBP) | 31/03/2024 | |||
Quarter 1 | Quarter 2 | Quarter 3 | Quarter 4 | |
2024 | 3.71 | - | - | - |
2023 | -5.08 | -0.50 | -0.62 | 8.13 |
2022 | -4.89 | -0.25 | 12.79 | 2.48 |
2021 | -5.73 | 6.89 | 0.69 | -3.04 |
2020 | -4.92 | 25.51 | -5.56 | 4.07 |
2019 | 13.85 | 1.54 | -5.89 | 18.26 |
|
Advertisement |